![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Autoimmune Disorders |
Free Subscription
1 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
An intervention design for promoting quality of life among patients with multiple
sclerosis: a protocol with a planning approach for a mixed methods study.
BMC Neurol. 2023;23:42.
PubMed
Abstract available
Gut microbiome associated with Graves' disease and Graves' orbitopathy: the
INDIGO* multi-centre European study.
J Clin Endocrinol Metab. 2023 Jan 23:dgad030. doi: 10.1210.
PubMed
Abstract available
IFN-Induced Protein with Tetratricopeptide Repeats 2 Limits Autoimmune
Inflammation by Regulating Myeloid Cell Activation and Metabolic Activity.
J Immunol. 2023 Jan 25:ji2200746. doi: 10.4049/jimmunol.2200746.
PubMed
Abstract available
Iron metabolism in non-anemic myasthenia gravis patients: A cohort study.
J Neuroimmunol. 2023;375:578015.
PubMed
Abstract available
Complementary medicine and phospholipase A2 receptor (PLA2R)-related membranous
nephropathy-fortuitous or causal?
Kidney Int. 2023;103:425-427.
PubMed
False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus.
Kidney Int. 2023;103:425.
PubMed
A disease-modifying approach to the treatment of IgA nephropathy targeting
mucosal IgA synthesis and beyond.
Kidney Int. 2023;103:258-261.
PubMed
Abstract available
Toward a bona fide animal model of PLA2R1-associated membranous nephropathy: one
step forward.
Kidney Int. 2023;103:251-253.
PubMed
Abstract available
Anomalous kinetics of galactose-deficient IgA incurring nephropathy revealed by
cross-scale optical imaging.
Kidney Int. 2023;103:320-330.
PubMed
Abstract available
Results from part A of the multi-center, double-blind, randomized,
placebo-controlled NefIgArd trial, which evaluated targeted-release formulation
of budesonide for the treatment of primary immunoglobulin A nephropathy.
Kidney Int. 2023;103:391-402.
PubMed
Abstract available
Tumefactive multiple sclerosis presents with painless progressive hemiparesis and
aphasia.
Lancet. 2023;401:226.
PubMed
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring
treatment response in multiple sclerosis.
Mult Scler. 2023 Jan 22:13524585221147635. doi: 10.1177/13524585221147635.
PubMed
Abstract available
The Canadian Multiple Sclerosis Pregnancy Study: First-trimester miscarriages in
women with multiple sclerosis.
Mult Scler. 2023 Jan 22:13524585221146270. doi: 10.1177/13524585221146270.
PubMed
Abstract available
Deep gray matter substructure volumes and depressive symptoms in a large multiple
sclerosis cohort.
Mult Scler. 2023 Jan 24:13524585221148144. doi: 10.1177/13524585221148144.
PubMed
Abstract available
Corpus callosum involvement in MOG antibody-associated disease in comparison to
AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple
sclerosis.
Mult Scler. 2023 Jan 24:13524585221150743. doi: 10.1177/13524585221150743.
PubMed
Abstract available
Pathologic Features of Anti-Mi-2 Dermatomyositis.
Neurology. 2023 Jan 24:10.1212/WNL.0000000000201611.
PubMed
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and
AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
Neurology. 2023 Jan 23:10.1212/WNL.0000000000206820.
PubMed
Abstract available
Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with
meningoencephalitis of unknown origin.
PLoS One. 2023;18:e0280864.
PubMed
Abstract available
Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results
of two observational studies.
PLoS One. 2023;18:e0276423.
PubMed
Abstract available
Reliability and measurement error of anterior maximum voluntary bite force in
children with juvenile idiopathic arthritis and healthy children.
PLoS One. 2023;18:e0280763.
PubMed
Abstract available
Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer
patients.
PLoS One. 2023;18:e0279450.
PubMed
Abstract available
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication
of CD20-expressing CD8 T cells in MS disease activity.
Proc Natl Acad Sci U S A. 2023;120:e2207291120.
PubMed
Abstract available
Incidence of and Risk Factors for Neonatal Hypothyroidism among Women with
Graves' Disease Treated with Antithyroid Drugs until Delivery.
Thyroid. 2023 Jan 21. doi: 10.1089/thy.2022.0514.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by